Abstract
Summary
This study evaluated the number of comorbidities between two normal values of 25OHD in outpatients during 1 year of 25OHD measurements. Five hundred twenty-nine outpatients were included, patients with 25OHD ≥ 20 and < 30 ng/mL had the higher number of comorbidities, suggesting that for this specific population, 25OHD ≥ 30 ng/mL would be more appropriate.
Introduction
This study evaluated the comorbidities between two values of 25OHD in outpatients of a tertiary hospital.
Methods
This is a cross-sectional study with measures of 25OHD in 1-year period, excluding 25OHD < 20 and > 50 ng/mL, clinical research participants, and liver disease and chronic renal failure patients. Patients were divided into two groups: group 1 (G1), 25OHD ≥ 20 and < 30 ng/mL; and group 2 (G2), 250HD ≥ 30 and ≤ 50 ng/mL. Medical records were reviewed for demographic, laboratory, and comorbidity data.
Results
From 529 outpatients included, 319 were in G1 (53.3 ± 15.8 years, 85% women), mean 25OHD 24.8 ± 2.8 ng/mL; and 210 outpatients in G2 (56.7 ± 16.0 years, 83% women), mean 25OHD was 36.8 ± 4.8 ng/mL. G1 had the higher number of comorbidities, including altered glycemia, dyslipidemia, hypothyroidism, urinary tract diseases, arthropathy, secondary hyperparathyroidism, anemia, and neurological and psychiatric disorders. Osteoporosis and hypothyroidism were more prevalent in G2. After binary logistic regression, the variables age (OR 0.988, CI 0.97–1.00, p = 0.048), osteoporosis (OR 0.54, CI 0.36–0.80, p = 0.003), dyslipidemia (OR 1.61, CI 1.10–2.39, p = 0.015), arthropathy (OR 2.60, CI 1.40–5.10, p = 0.003), anemia (OR 15.41, CI 3.09–280.08, p = 0.008), and neurological and psychiatric diseases (OR 3.78, CI 1.98–7.88, p = 0.001) maintained significance.
Conclusion
Patients with serum 25OHD ≥ 20 and < 30 ng/mL had higher prevalence of comorbidities compared to ≥ 30 ng/mL.
Similar content being viewed by others
References
Maeda SS, Saraiva GL, Hayashi LF, Cendoroglo MS, Ramos LR, Corrêa Mde P, Henrique de Mesquita C, Lazaretti-Castro M (2013) Seasonal variation in the serum 25-hydroxyvitamin D levels of young and elderly active and inactive adults in São Paulo, Brazil: The São PAulo Vitamin D Evaluation Study (SPADES). Dermatoendocrinol 5(1):211–217. https://doi.org/10.4161/derm.24476
Correia A, Azevedo MDS, Gondim F, Bandeira F (2014) Ethnic aspects of vitamin D deficiency. Arq Bras Endocrinol Metabol 58(5):540–544. https://doi.org/10.1590/0004-2730000003320
Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J (2009) IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820. https://doi.org/10.1007/s00198-009-0954-6
Arantes HP, Kulak CAM, Fernandes CE, Zerbini C, Bandeira F, Barbosa IC, Brenol JCT, Russo LA, Borba VC, Chiang AY, Bilezikian JP, Lazaretti-Castro M (2013) Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial. Osteoporos Int 24(10):2707–2712. https://doi.org/10.1007/s00198-013-2366-x
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al editors (2011) Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK56070/. doi: 10.17226/13050
Holick MF, Binkley NC, H a B-F, Gordon CM, D a H, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385
Schramm S, Lahner H, Jöckel KH, Erbel R, Führer D, Moebus S, Heinz Nixdorf Recall Study Group (2017) Impact of season and different vitamin D thresholds on prevalence of vitamin D deficiency in epidemiological cohorts—a note of caution. Endocrine 56(3):658–666
Prentice A (2008) Vitamin D deficiency: a global perspective. Nutr Rev 66(10 Suppl 2):S153–S164. https://doi.org/10.1007/s12020-017-1292-7
Muschitz C, Kocijan R, Stütz V, Kaider A, Muschitz GK, Resch H, Kapiotis S (2015) Vitamin D levels and comorbidities in ambulatory and hospitalized patients in Austria. Wien Klin Wochenschr 127(17–18):675–684. https://doi.org/10.1007/s00508-015-0824-5
Callegari ET, Reavley N, Garland SM, Gorelik A, Wark JD (2015) Vitamin D status, bone mineral density and mental health in young Australian women: the Safe-D Study. J Public Health Res 4(3):594. https://doi.org/10.4081/jphr.2015.594
Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678–1688
Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79(3):362–371
Williams R, Novick M, Lehman E (2014) Prevalence of hypovitaminosis D and its association with comorbidities of childhood obesity. Perm J 18(4):32–39. https://doi.org/10.7812/TPP/14-016
Chinellato I, Piazza M, Sandri M, Peroni D, Piacentini G, Boner AL (2011) Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr 158(3):437–441. https://doi.org/10.1016/j.jpeds.2010.08.043
Neuerburg C, Mittlmeier L, Schmidmaier R, Kammerlander C, Böcker W, Mutschler W, Stumpf U (2017) Investigation and management of osteoporosis in aged trauma patients: a treatment algorithm adapted to the German guidelines for osteoporosis. J Orthop Surg Res 12(1):86. https://doi.org/10.1186/s13018-017-0585-0
Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Scazufca M, Bonfá E, Pereira RM (2009) Vitamin D insufficiency: a risk factor to vertebral fractures in community-dwelling elderly women. Maturitas 64(4):218–222. https://doi.org/10.1016/j.maturitas.2009.09.020
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327(23):1637–1642
Kristal-Boneh E, Froom P, Harari G, Ribak J (1997) Association of calcitriol and blood pressure in normotensive men. Hypertension 30(5):1289–1294. https://doi.org/10.1161/01.HYP.30.5.1289
Scragg R, Jackson R, Holdaway IM (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D 3 levels: a community based study. Int J Epidemiol 19(3):559–563. https://doi.org/10.1093/ije/19.3.559
Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96(6):1755–1760. https://doi.org/10.1161/01.CIR.96.6.1755
Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB, Intermountain Heart Collaborative (IHC) Study Group (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106(7):963–968. https://doi.org/10.1016/j.amjcard.2010.05.027
Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167(11):1159–1165. https://doi.org/10.1001/archinte.167.11.1159
Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F, Salas-Salvadó J (2012) Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 11:149. https://doi.org/10.1186/1475-2840-11-149
Griz L, Bandeira F, Gabbay M (2014) Vitamin D and diabetes mellitus: an update 2013. Arq Bras Endocrinol Metab 1(8):1–8
Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, Hashimoto S, Itoh M (2006) Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 53(4):503–510
Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A (2010) The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract 64(3):351–355. https://doi.org/10.1111/j.1742-1241.2009.02221.x
Pittas AG, Stark PC, Harris SS, Dawson-Hughes B (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30(4):980–986. https://doi.org/10.2337/dc06-1994
Mitri J, Dawson-Hughes B, Hu FB, Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94(2):486–494. https://doi.org/10.3945/ajcn.111.011684
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690–693
Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Neuhouser ML, Li L, W Jeffery R, Robien K, Alfano CM, Blackburn GL, McTiernan A (2011) Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94(1):95–103. https://doi.org/10.3945/ajcn.111.015552
Canto-Costa MH, Kunii I, Hauache OM (2006) Body fat and cholecalciferol supplementation in elderly homebound individuals. Braz J Med Biol Res 39(1):91–98. https://doi.org/10.1590/S0100-879X2006000100011
Sim JJ, Lac PT, Liu IL, Meguerditchian SO, Kumar VA, Kujubu DA, Rasgon SA (2010) Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol 89(5):447–452. https://doi.org/10.1007/s00277-009-0850-3
Mackawy AMH, Al-Ayed BM, Al-Rashidi BM (2013) Vitamin D deficiency and its association with thyroid disease. Int J Health Sci 7(3):267–275. 10.12816/0006054
Anglin RE, Samaan Z, Walter SD, McDonald SD (2013) Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 202(2):100–107. https://doi.org/10.1192/bjp.bp.111.106666
Bičíková M, Dušková M, Vítků J, Kalvachová B, Řípová D, Mohr PSL (2015) Vitamin D in anxiety and affective disorders. Physiol Res 64(Suppl 2):101–103
Kjærgaard M, Waterloo K, Wang CE, Almås B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 201(5):360–368. https://doi.org/10.1192/bjp.bp.111.104349
Tekin M, Konca C, Celik V, Almis H, Kahramaner Z, Erdemir A, Gulyuz A, Uckardes F, Turgut M (2015) The association between vitamin D levels and urinary tract infection in children. Horm Res Paediatr 83(3):198–203. https://doi.org/10.1159/000370046
Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F, Lazaretti-Castro M, Brazilian Society of Endocrinology and Metabology (SBEM) (2014) Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arq Bras Endocrinol Metabol 58(5):411–433
Autier P, Boniol M, Pizot C, Mullie P (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2(1):76–89. https://doi.org/10.1016/S2213-8587(13)70165-7
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the research ethics committee (CEP-HC-UFPR), 46017715.0.3001.0096.
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Furuie, I.N., Mauro, M.J.J., Petruzziello, S. et al. Two threshold levels of vitamin D and the prevalence of comorbidities in outpatients of a tertiary hospital. Osteoporos Int 29, 433–440 (2018). https://doi.org/10.1007/s00198-017-4299-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-017-4299-2